This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Overview of the Current use of Sugammadex in High-risk Patients, and the Potential Benefits of Deep Neuromuscular Blockade

Download the following summary which received input from an independent anaesthetist (Dr John Cousins, Imperial College Healthcare NHS Trust) and an independent surgeon (Mr Ahmed Ahmed, Imperial College Healthcare NHS Trust) to develop this summary document looking at the published evidence for sugammadex, based on the following high-risk patient groups: patients with cardiovascular disease, the obese, the elderly, and those with respiratory issues. Mr Ahmed also suggested expanding the scope of the document to look at the use of deep block in laparoscopic surgery.

More information about BRIDION® (sugammadex):

Supporting documentation

GB-XBR-00010 | Date of Preparation: January 2019